About Andrew Phillips
Andrew Phillips is a director at Kestrel Therapeutics.
Andrew Phillips first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Phillips in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Phillips works with at each company, as listed on that company's latest Form D.
Kestrel Therapeutics Inc. · Form D, Aug 12, 2025
NS
Nicholas Saccomano
Director
DP
Denis Patrick
Director
BS
Barbara Sosnowski
Director
OK
Omar Khalil
Director
FH
Frank Haluska
President and Chief Executive Officer, director